Jun 9, 2014 by Mohsin SaeedWhy I Like Actavis StockThe generics are less flashy investments as compared to biotechnology companies. However, they also carry much less risk and offer steady growth to investors.
May 13, 2014 by Mohsin SaeedCan SunEdison Inc Overcome the Competition?The solar industry a highly competition space with ample growth opportunities but SunEdison needs to focus on balance sheet problems from now.
Nov 25, 2013 by Mohsin SaeedSequenom Is Recovering on Some Good NewsLet's take a look at how Sequenom has bounced back recently.
Oct 24, 2013 by Mohsin SaeedPartnerships Have Been a Boost for InovioA look at biotech company Inovio and its future prospects.
